Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands
Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
BMJ Open. 2024 Feb 17;14(2):e081655. doi: 10.1136/bmjopen-2023-081655.
The number of patients with colorectal cancer (CRC) in need of oncological follow-up is growing. As a response, patient-led, home-based follow-up (PHFU) was developed, implemented and assessed. The aim of this study was to investigate how patients experienced PHFU.
A qualitative study with individual semistructured interviews. Interviews were transcribed verbatim, and thematically analysed through an inductive, double-coding approach.
A university medical centre in the Netherlands.
12 curatively treated patients with CRC who received PHFU were included after purposive sampling.
Overall, participants (N=12) were satisfied with PHFU. The time and cost-saving aspects for patient and hospital were evidently valued. PHFU was experienced as a shared effort, but patients felt like the primary responsibility remained in the hospital. Patients mentioned a decreased personal interaction with their healthcare provider (HCP) and felt a higher threshold to ask for help. However, all major questions were still addressed. Patients felt sufficiently competent to interpret their individual test results but experienced difficulty in interpreting repeated increases in carcinoembryonic antigen levels within the normal range. Educational status, age and a complicated disease course were seen as factors limiting the applicability of PHFU, and it was expressed that PHFU should be offered as an alternative instead of a novel standard of care.
According to patients, PHFU has great potential. However, PHFU may not be suitable for every CRC patient, and factors such as educational status, age and disease course should be taken into consideration. Patient and HCP have a shared responsibility to help successfully organise PHFU in practice.
需要进行肿瘤随访的结直肠癌(CRC)患者数量正在增加。作为回应,开发、实施并评估了患者主导的家庭随访(PHFU)。本研究旨在调查患者对 PHFU 的体验。
一项采用个体半结构式访谈的定性研究。访谈逐字记录,并通过归纳、双编码方法进行主题分析。
荷兰的一所大学医学中心。
在经过目的性抽样后,共纳入 12 名接受 PHFU 的接受根治性治疗的 CRC 患者。
总体而言,参与者(N=12)对 PHFU 感到满意。对患者和医院来说,节省时间和成本的方面显然受到重视。PHFU 被视为共同努力,但患者觉得主要责任仍在医院。患者提到与他们的医疗保健提供者(HCP)的个人互动减少,并感到求助的门槛更高。然而,所有主要问题仍得到解决。患者觉得自己有足够的能力来解释他们的个体检测结果,但在解释癌胚抗原水平在正常范围内反复升高时感到困难。教育程度、年龄和复杂的疾病过程被视为限制 PHFU 适用性的因素,并表示 PHFU 应该作为替代方案而不是一种新的护理标准提供。
根据患者的说法,PHFU 具有很大的潜力。然而,PHFU 可能并不适合每个 CRC 患者,并且应考虑诸如教育程度、年龄和疾病过程等因素。患者和 HCP 有共同的责任来帮助在实践中成功组织 PHFU。